An ethics committee evaluates a research proposal by systematically assessing whether the study protects participants from harm, upholds informed consent, ensures fair subject selection, and maintains scientific integrity. The review process applies to any research involving human subjects, sensitive data, or significant societal risk. The sections below address the most common questions researchers and institutional leaders have about navigating ethical review.
What criteria does an ethics committee use to assess research?
An ethics committee evaluates a research proposal against a core set of principles: respect for persons, beneficence, and justice. These principles, widely recognized across international research ethics frameworks, translate into specific criteria that reviewers apply to every submission, regardless of discipline or methodology.
In practice, reviewers assess the following areas:
- Scientific validity: A study that is poorly designed cannot produce reliable results, and exposing participants to risk for inconclusive findings is itself an ethical problem.
- Informed consent procedures: Participants must understand what they are agreeing to, including any risks, before they enroll. Committees scrutinize consent forms for clarity, completeness, and accessibility.
- Risk-benefit ratio: The anticipated benefits to participants or society must be proportionate to the risks involved. Reviewers look for evidence that risks have been minimized through study design.
- Participant selection and equity: The research proposal must demonstrate that participants are selected fairly and that vulnerable populations are not exploited or unnecessarily excluded.
- Data privacy and confidentiality: Committees examine how personal data will be collected, stored, and protected throughout the study lifecycle.
- Conflict of interest: Reviewers consider whether financial or professional relationships could compromise the integrity of the research or the welfare of participants.
These criteria apply whether the committee is a national institutional review board (IRB), a hospital ethics panel, or an international research oversight body. The ethical review process is not a bureaucratic formality but a substantive check on research quality and participant protection.
What types of research require ethics committee approval?
Any research involving human participants, identifiable personal data, or interventions that carry physical or psychological risk typically requires ethics committee approval. This includes clinical trials, social science surveys, interviews, observational studies, and research using biological samples or health records.
Beyond the obvious categories, ethics review is also required for:
- Secondary data analysis using identifiable information, even if collected by another institution
- Research conducted in low-resource or conflict-affected settings where power imbalances may compromise voluntary participation
- Studies involving children, prisoners, pregnant women, or other groups classified as vulnerable under national or international guidelines
- Digital and online research that collects behavioral data, location information, or private communications
- AI and machine learning research that trains models on personal datasets
Research that uses fully anonymized, publicly available datasets and involves no direct participant contact may qualify for an exemption, but this determination must still be made formally by the ethics committee rather than assumed by the researcher.
How long does the ethics committee review process take?
The ethics committee review process typically takes between two weeks and six months, depending on the type of review required, the complexity of the proposal, and the committee’s meeting schedule. Expedited reviews for minimal-risk research can be completed in two to four weeks, while full board reviews for complex or high-risk studies often take two to four months.
Several factors influence the timeline:
- Completeness of the submission: Incomplete applications are the most common cause of delay. Missing consent forms, protocol documents, or researcher qualifications can pause the clock entirely.
- Committee meeting frequency: Many full boards meet monthly. A submission that misses the deadline for one cycle waits until the next.
- Number of revision rounds: If the committee requests modifications, each round of revisions adds time. Proposals that require two or three rounds of clarification can extend the process significantly.
- Multi-site or multi-country research: Studies conducted across jurisdictions may require parallel approvals from multiple ethics bodies, each with its own timeline.
Researchers working within institutional or government-funded programs should build ethics review time into their project planning from the outset, treating it as a structured phase rather than an administrative afterthought.
What are the most common reasons a research proposal gets rejected?
The most common reasons a research proposal is rejected by an ethics committee are inadequate informed consent procedures, an unfavorable risk-benefit ratio, insufficient participant protections for vulnerable groups, and poor scientific design. In many cases, outright rejection is rare; committees more frequently issue conditional approvals requiring revisions.
Recurring issues that lead to rejection or significant revision requests include:
- Consent forms written in technical language that participants cannot reasonably understand
- Failure to justify why a vulnerable population is included when a less vulnerable group could serve the same research purpose
- Vague or inadequate data security plans, particularly for digital or health data
- Underestimating or failing to disclose foreseeable risks to participants
- Research questions that lack sufficient scientific grounding to justify participant exposure to any level of risk
- Conflicts of interest that are undisclosed or inadequately managed
Understanding these patterns helps research teams conduct a rigorous internal review before submission, reducing the likelihood of avoidable delays in the ethical review process.
What’s the difference between full board review and expedited review?
Full board review requires the entire ethics committee to convene and deliberate on a proposal, and it applies to research that poses more than minimal risk to participants. Expedited review is conducted by one or a small number of designated reviewers and is reserved for research that presents no more than minimal risk and fits within pre-approved categories of low-risk activity.
Full board review
Full board review is the more rigorous pathway. The complete committee meets, discusses the proposal, and votes on approval. This process is required for clinical interventions, studies involving vulnerable populations, research with significant psychological or social risk, and any study where the risk-benefit balance warrants collective deliberation. Full board review takes longer and requires more comprehensive documentation.
Expedited review
Expedited review does not mean a less thorough review, only a more streamlined one. It applies when a study falls into recognized low-risk categories, such as anonymous surveys, non-invasive observational research, or secondary analysis of de-identified data. A designated reviewer or small subcommittee assesses the proposal against the same ethical criteria, but without convening the full board. The result is a faster turnaround while maintaining ethical rigor.
Researchers should not assume their study qualifies for expedited review. The ethics committee makes that determination based on the actual content of the proposal, not the researcher’s preference.
How can research organizations strengthen their ethics submissions?
Research organizations can strengthen their ethics submissions by investing in clear documentation, early internal review, and systematic training in research ethics standards. Strong submissions anticipate reviewer concerns rather than reacting to them, presenting a complete and coherent picture of participant protections, data handling, and scientific rationale from the outset.
Practical steps that consistently improve submission quality include:
- Using plain language in consent materials: Write consent forms at a reading level appropriate for the target participant population, and test comprehension with a small sample before submission.
- Conducting a pre-submission internal review: Assign a colleague not involved in the study to read the protocol and flag gaps before the formal submission.
- Documenting risk mitigation explicitly: Do not assume reviewers will infer that risks have been considered. State each foreseeable risk and describe the specific measures in place to minimize it.
- Aligning with international frameworks: Reference recognized standards such as the Declaration of Helsinki or the Belmont Report where relevant, demonstrating awareness of the broader ethical landscape.
- Maintaining ongoing ethics training: Research teams that regularly engage with ethics education produce stronger proposals and respond more effectively to committee feedback.
Institutional capacity to manage the ethical review process is not just a compliance matter. It reflects the organization’s commitment to responsible research practice and strengthens its credibility with funders, partners, and the communities it serves.
How WAITRO supports research organizations through the ethics review process
Navigating the ethical review process requires more than procedural knowledge. It demands strong institutional systems, well-trained teams, and the organizational capacity to embed responsible research practices at every level. This is precisely where we can help.
Through our Capacity Development Program, we work directly with research and technology organizations to build the institutional foundations that make ethics compliance a natural part of research culture rather than a last-minute hurdle. Specifically, we support member organizations by:
- Strengthening project coordination and documentation practices that underpin strong ethics submissions
- Building strategic planning skills that integrate ethics review timelines into research design from the start
- Enhancing institutional communication frameworks so that research teams can present their protocols clearly and persuasively to review bodies
- Supporting thematic capacity in areas such as AI, digital transformation, and sustainability, where ethical considerations are particularly complex and rapidly evolving
We also connect member organizations with a global network of research institutions, including world-leading bodies like Fraunhofer and Leitat, creating opportunities to share ethics governance models and learn from established best practices across different regulatory environments.
If your organization is looking to strengthen its research ethics capacity and build more credible, compliant, and impactful research programs, become a WAITRO member and explore what our Capacity Development Program can offer your institution.
